Neurovance
Latest round
- Series A
Last raised
- Mar 2015
Total raised
- $19M
Investors
- 6
About Neurovance
Founded in 2011 and based in Cambridge, Massachusetts, Neurovance operates as a clinical stage neuroscience-focused company developing EB-1020 SR for adults who suffer from ADHD.
Who invested in Neurovance
6 investors across 5 rounds
See all investors in Neurovance
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neurovance
Who invested in Neurovance?
Neurovance has 6 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neurovance raised?
Neurovance has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Neurovance last raise money?
Neurovance's most recent round on record is a Series A, in Mar 2015.
What does Neurovance do?
Founded in 2011 and based in Cambridge, Massachusetts, Neurovance operates as a clinical stage neuroscience-focused company developing EB-1020 SR for adults who suffer from ADHD.
Where is Neurovance headquartered?
Neurovance is headquartered in Cambridge, US.
Which VCs invest in companies like Neurovance?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Neurovance's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Neurovance? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.